Montana Bioscience Updates

Applications for Translational Research Scholars Program Due Feb. 17

February 1, 2017
No Comments

The ITHS Translational Research Scholars Program (formerly Rising Stars) is now accepting applications for our 2017 cohort. The program welcomes early stage investigators from the WWAMI-region. BENEFITS The program offers a high-quality, targeted, and structured career development package for one year. Benefits include: $10,000 in funding to conduct research and develop career skills Mentorship from established translational […]

December 15, 2016
No Comments

Golden Helix is a leader in analytics software tools geared towards the clinical genetic testing market and research institutions. Globally, we do business with hundreds of organizations. We have a strong record with major hospitals, testing labs, research organizations, the pharma industry as well as governments worldwide. Our business is growing, creating the need to […]

New biotech company forms at University of Montana business incubator

November 4, 2016
No Comments

Two dozen good-paying scientific research jobs almost left western Montana for Maryland last year – but they ended up here in Missoula thanks to an innovative partnership with the University of Montana. GlaxoSmithKline Vaccines, a giant pharmaceutical company with an office in Hamilton, announced in February 2015 that it was consolidating its research and development […]

DermaXon received a Phase 1 STTR Grant funding from the National Institute of Arthritis

October 9, 2016
No Comments

DermaXon received a Phase 1 STTR Grant funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to support preclinical efficacy studies for a novel drug treatment for ichthyosis. DermaXon a biotech company located in Missoula, Montana announced today a $215,000 Phase 1 Small Business Technology Transfer (STTR) award from the National Institute […]

October 8, 2015
No Comments

WHAT: National Institutes of Health (NIH) scientists studying inflammation of the brain have discovered why certain immune responses, which typically help cells recognize and fight viral and bacterial infections, can sometimes be harmful to the brain. Many brain disorders involve the death of neurons, or nerve cells, but how these neurons die […]

August 27, 2015
No Comments

FOR IMMEDIATE RELEASE Wednesday, Aug. 19, 2015 2 p.m. Eastern Time MEDIA AVAILABILITY NIH Scientists and Colleagues Successfully Test MERS Vaccine in Monkeys and Camels WHAT: National Institutes of Health (NIH) scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects […]

August 14, 2015
No Comments

The National Center for Advancing Translational Sciences (NCATS) has several open funding opportunities available for small businesses interested in commercializing translational technologies. Interested applicants are encouraged to review each funding opportunity and schedule a one-on-one meeting with NCATS leaders to discuss a project or collaboration idea. Email NCATS-SBIRSTTR@mail.nih.gov to make an appointment. Learn more at NCATS SBIR and STTR Omnibus […]

August 14, 2015
No Comments

The news item below relates to a study done at Rocky Mountain Laboratories and released today in the journal Science. This is the same vaccine cited in last Friday’s report in The Lancet about a successful human clinical trial in Guinea. EMBARGOED FOR RELEASE Thursday, Aug. 6, 2015 2:00 p.m. Eastern Time MEDIA AVAILABILITY Single Dose […]

Montana Bioscience Updates

Applications for Translational Research Scholars Program Due Feb. 17

Area Director of Sales – Golden Helix

New biotech company forms at University of Montana business incubator

DermaXon received a Phase 1 STTR Grant funding from the National Institute of Arthritis

NIH Scientists Identify How Normally Protective Immune Responses Kill Neurons

NIH Scientists and Colleagues Successfully Test MERS Vaccine in Monkeys and Camels

Open Funding Opportunities from NCATS; First Deadline: Sept 8, 2015

Single Dose Ebola Vaccine is Safe and Effective in Monkeys Against Outbreak Strain